Picture of Vioquest Pharmaceuticals logo

VOQP Vioquest Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Vioquest Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2003
December 31st
2004
December 31st
C2005
December 31st
2006
December 31st
2007
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSB/A10KSB10KSB10KSB
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.02-4.02-12.8-8.27-10.9
Depreciation
Non-Cash Items0.2370.2968.441.462.16
Discontinued Operations
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital0.059-0.2380.650.3491.64
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-1.64-3.79-3.74-6.46-7.08
Capital Expenditures-0.368-0.549-0.021-0.028-0.005
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0-0.764-0.2531.7
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-0.368-0.549-0.785-0.2811.7
Financing Cash Flow Items2.970
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.636.747.483.653.15
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.6262.412.96-3.09-2.24